Nobligan (Tramadol Hydrochloride)

Tramadol Hydrochloride, the active ingredient in Nobligan, is an opioid analgesic presented as an oral tablet for oral use. It treats moderate to severe pain in adult patients when prescribed by a healthcare professional. GNH USA supplies Nobligan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nobligan, an opioid analgesic, is indicated for pain conditions that require central analgesia. - Acute postoperative pain: provides effective relief after surgical procedures. - Chronic musculoskeletal pain: helps manage persistent pain from conditions such as osteoarthritis. - Cancer‑related pain (moderate): contributes to pain control when opioid therapy is indicated.

Tramadol may cause a range of adverse reactions, from frequent to rare.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: sensation of light‑headedness or unsteadiness. - Constipation: reduced bowel movements. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness or fatigue. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Seizures: risk increased in susceptible individuals. - Respiratory depression: slowed breathing, especially at high doses. - Serotonin syndrome: potentially life‑threatening when combined with serotonergic drugs. - Allergic reactions: rash, itching, or swelling. - Hypotension: marked drop in blood pressure. - Dependence or addiction: risk of misuse with prolonged use.

When prescribing or dispensing Nobligan, consider the following safety measures. - Assess renal and hepatic function: adjust therapy if impairment is present. - Avoid use in patients with a history of seizures: tramadol may lower seizure threshold. - Monitor for signs of serotonin syndrome: especially when combined with serotonergic agents. - Use caution in elderly patients: increased risk of falls and constipation. - Avoid abrupt discontinuation: may cause withdrawal symptoms. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Tramadol interacts with several drug classes; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - SSRIs, SNRIs, and other serotonergic agents: risk of serotonin syndrome. - MAO inhibitors: may cause hypertensive crisis. - CNS depressants (benzodiazepines, alcohol): enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): increase tramadol plasma levels. - CYP3A4 inducers (e.g., carbamazepine, rifampin): reduce analgesic effect. - Anticoagulants (warfarin): possible increased bleeding risk.